TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Female
KW - Humans
KW - Narcotic Antagonists/therapeutic use
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Prescription Drug Monitoring Programs
KW - Washington
KW - buprenorphine
KW - Longitudinal analysis
KW - opioid use disorder
KW - Prescribing
KW - Treatment discontinuation
AU - C. J. Banta-Green
AU - R. N. Hansen
AU - E. M. Ossiander
AU - C. R. Wasserman
AU - J. O. Merrill
A1 - 
AD - Addictions, Drug & Alcohol Institute, Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, 1107 NE 45th St, Suite 120, Seattle, WA 98105, United States of America. Electronic address: calebbg@uw.edu.; School of Pharmacy University of Washington, Box 357630, Seattle, WA 98195-7630, United States of America.; Washington State Department of Health, 101 Israel Road SE, Tumwater, WA 98501, United States of America.; Washington State Department of Health, 101 Israel Road SE, Tumwater, WA 98501, United States of America.; Department of Medicine, University of Washington, Harborview Medical Center, 401 Broadway, Seattle, WA 98122, United States of America.
BT - Journal of substance abuse treatment
C5 - Financing & Sustainability; Opioids & Substance Use
CY - United States
DO - 10.1016/j.jsat.2021.108446
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2021
SN - 1873-6483; 0740-5472
SP - 108446
T1 - Buprenorphine utilization among all Washington State residents' based upon prescription monitoring program data - Characteristics associated with two measures of retention and patterns of care over time
T2 - Journal of substance abuse treatment
TI - Buprenorphine utilization among all Washington State residents' based upon prescription monitoring program data - Characteristics associated with two measures of retention and patterns of care over time
U1 - Financing & Sustainability; Opioids & Substance Use
U2 - 34049724
U3 - 10.1016/j.jsat.2021.108446
VL - 127
VO - 1873-6483; 0740-5472
Y1 - 2021
Y2 - Aug
ER -